Fluorescence microscope for neurosurgery

Help us bring fluorescence-guided surgery for malignant brain tumours to Canada and give new hope to patients with this devastating diagnosis.

Every year about 1,000 Canadians will be diagnosed with glioblastoma, the most aggressive and most common form of cancer that originates in the brain. Fewer than 10 percent will survive five years after diagnosis.

Current techniques don’t allow Neurosurgeons to see these invasive cancer cells in real time. Under a regular white light microscope, it is difficult to tell the difference between tumour tissue and normal brain tissue. We want to bring fluorescence guided surgery to The Ottawa Hospital.

“Fluorescence-guided surgery is much more effective for brain cancers than surgeries performed with traditional white light. It is a dramatic difference which helps the surgeon to remove more cancerous cells with improved accuracy, which benefits the patient in multiple ways.” – Dr. John Sinclair, Neurosurgeon, The Ottawa Hospital

Why Us

The Ottawa Hospital is already a leader in neurosurgery. We perform more awake brain surgeries than anywhere else in Canada. Thanks to generous donor support, we are one of only three hospitals in Canada to have a CyberKnife radiosurgery robot to treat inoperable malignant and benign tumours in the head and body.

Your Impact

With your financial support The Ottawa Hospital will be able to offer this surgery. This technique has the potential to improve prognosis and quality of life for those diagnosed with this life changing cancer. It is an important addition to our existing therapies. Closing this treatment gap will provide our brain tumour patients with world-class care unavailable almost anywhere else in Canada.

Our Goal

We are raising $1 million to purchase a state-of-the-art fluorescence microscope for neurosurgery. We are looking for community leaders, grateful patients, and generous individuals to make our vision a reality for our patients.

Should you want any further information on this important project, please contact Julie Beckett at 613-850-6135 or jbeckett@toh.ca.

Help us bring fluorescence-guided surgery for malignant brain tumours to our patients.